Stock Analysis
Perrigo Company plc (PRGO) Stock Analysis
Perrigo Company plc (PRGO) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Perrigo Company plc (PRGO) currently has an AIQ Score of 56/100, indicating a neutral setup. Momentum is the strongest factor at 78/100. Quality is the weakest current factor at 25/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
PRGO at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $14.92 |
| AIQ Score | 56/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $2B |
| P/E Ratio | 5.77 |
| Forward P/E | — |
| EPS | $0.54 |
| Revenue TTM | $1.02B |
| Dividend Yield | 0.06% |
| Beta | 0.54 |
| Volume | 2.2M |
| 52-week range | $9.23-$23.68 |
| RSI 14 | 74.65 |
| 50-Day SMA | $11.94 |
| 200-Day SMA | $12.20 |
| Analyst Price Target | $20.00 |
| Next Earnings | Nov 4, 2026 |
PRGO
OverviewPRGO Stock Analysis Summary
Perrigo Company plc (PRGO) currently has an AIQ Score of 56/100, indicating a neutral setup. Momentum is the strongest factor at 78/100. Quality is the weakest current factor at 25/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, PRGO has AIQ Score of 56/100 with Momentum base of 78/100 and fading Quality at 25/100. Wait for component alignment before adding exposure.
Momentum (78/100) leads while Quality (25/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 4.56% stock move · PRGO classified in Drug Manufacturers - Specialty & Generic.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is PRGO Bullish or Bearish Right Now?
PRGO currently has a neutral overall setup. Momentum is the strongest factor at 78/100, while Quality is weakest at 25/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 78/100.
- - Price is +24.91% above its 50-day SMA.
- - Analyst target implies +34.05% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (36 vs 6).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
PRGO's Technical Analysis Consensus is currently Strong Buy, with 36 buy, 3 neutral, and 6 sell votes. PRGO's 14-day RSI is 74.65, which places the stock in an overbought momentum range. PRGO's beta is 0.54, indicating lower market sensitivity than the broad market.
What Changed in PRGO?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the PRGO Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
PRGO Decision Framework
Public evidence layers, setup checks, and risk context for Perrigo Company plc.
Perrigo Company plc (PRGO) Stock Analysis
Perrigo Company plc has an AIQ Score of 56/100 in a Neutral regime. Momentum is strongest at 78/100. Beta is 0.54, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | PRGO is in a Neutral AIQ regime with score 56/100. |
| Signal Conflict | The primary conflict is that momentum leads at 78/100 while quality lags at 25/100. |
| Factor Evidence | Momentum 78/100 · Value 74/100 · Quality 25/100 · Risk 48/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 78/100.
Momentum is 78/100 and RSI (14) is 74.6.
PRGO is in a Neutral regime at 56/100.
Risk factor is 48/100 with beta 0.54 and annual volatility 54.76%.
Current conflict: momentum leads at 78/100 while quality lags at 25/100.
PRGO Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
PRGO Fundamentals
PRGO valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
PRGO Technical Analysis
PRGO technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
PRGO Stock Catalysts
Track PRGO earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
PRGO Dividend Analysis
PRGO dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
PRGO Financial Data
PRGO revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
PRGO Risk Analysis
PRGO volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
PRGO Stock News
PRGO stock news, market tone, recent headlines, and catalyst context.
PRGO vs Life Sciences / Tools / CRO Peers
Current peer cohort: PRGO · PTCT · RVTY · TECH · TMO. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| PRGO Current stock | 56/100 | 74/100 | 78/100 | 48/100 | -0.61 | 54.76% | Current |
| PTCT PTC Therapeutics | 53/100 | 38/100 | 33/100 | 61/100 | 0.55 | 40.39% | PRGO vs PTCT |
| RVTY Revvity | 57/100 | 42/100 | 81/100 | 64/100 | 1.2 | 37.79% | PRGO vs RVTY |
| TECH Bio-Techne | 56/100 | 26/100 | 62/100 | 89/100 | 0.82 | 46.71% | PRGO vs TECH |
| TMO Thermo Fisher Scientific | 51/100 | 39/100 | 60/100 | 62/100 | 0.77 | 30.64% | PRGO vs TMO |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 4, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 5, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 27, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching PRGO
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for PRGO
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
PRGO Stock FAQ
What is PRGO stock price today?
Perrigo Company plc's current stock price is $14.92. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is PRGO bullish or bearish right now?
PRGO's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is PRGO's market cap?
PRGO's market cap is $2B based on the latest completed market-close snapshot from Sep 4, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is PRGO's current P/E ratio?
PRGO's current P/E ratio is 5.77 based on the latest completed market-close snapshot from Sep 4, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is PRGO's RSI?
PRGO's 14-day RSI is 74.65 based on the latest completed market-close snapshot from Sep 4, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is PRGO above its 50-day and 200-day moving averages?
PRGO is 24.91% from its 50-day SMA and 22.31% from its 200-day SMA based on the latest completed market-close snapshot from Sep 4, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is PRGO's next earnings date?
PRGO's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does PRGO pay a dividend?
PRGO's dividend yield is 0.06% based on the latest completed market-close snapshot from Sep 4, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.